The potential role of the primary male androgen testosterone in prostate cancer is controversial. Many prostate tumors are known to be androgen responsive, and thus grow under the stimulation of male sex hormones. Whether or not these same hormones play a role in cancer initiation in the first place has been the subject of much […]

If there is one thing that underlines the growing expansion of the male HRT market in the Unites States, it is the rapid emergence of new testosterone medications. The past couple of years have seen a great deal of new drug development. We’ve had several new transdermal products approved by the FDA, including Axiron, Fortesta, […]